[go: up one dir, main page]

AU7972798A - Application of 13c-13c,13c-15n, and 13c-13c-15n isotopically enriched proteins as tissue-directed image-enhancement reagents for magnetic resonance imaging - Google Patents

Application of 13c-13c,13c-15n, and 13c-13c-15n isotopically enriched proteins as tissue-directed image-enhancement reagents for magnetic resonance imaging

Info

Publication number
AU7972798A
AU7972798A AU79727/98A AU7972798A AU7972798A AU 7972798 A AU7972798 A AU 7972798A AU 79727/98 A AU79727/98 A AU 79727/98A AU 7972798 A AU7972798 A AU 7972798A AU 7972798 A AU7972798 A AU 7972798A
Authority
AU
Australia
Prior art keywords
tissue
application
magnetic resonance
resonance imaging
isotopically enriched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79727/98A
Inventor
Gaetano T. Montelione
Stanley Stein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Rutgers Health
Original Assignee
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/878,022 external-priority patent/US6210655B1/en
Application filed by University of Medicine and Dentistry of New Jersey, Rutgers State University of New Jersey filed Critical University of Medicine and Dentistry of New Jersey
Publication of AU7972798A publication Critical patent/AU7972798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AU79727/98A 1997-06-18 1998-06-17 Application of 13c-13c,13c-15n, and 13c-13c-15n isotopically enriched proteins as tissue-directed image-enhancement reagents for magnetic resonance imaging Abandoned AU7972798A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/878,022 US6210655B1 (en) 1997-06-18 1997-06-18 Site-specific 13C-enriched reagents for diagnostic medicine by magnetic resonance imaging
US08878022 1997-06-18
US6325297P 1997-10-24 1997-10-24
US60063252 1997-10-24
PCT/US1998/012568 WO1998057578A1 (en) 1997-06-18 1998-06-17 Application of ?13c-13c, 13c-15n, and 13c-13c-15¿n isotopically enriched proteins as tissue-directed image-enhancement reagents for magnetic resonance imaging

Publications (1)

Publication Number Publication Date
AU7972798A true AU7972798A (en) 1999-01-04

Family

ID=26743203

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79727/98A Abandoned AU7972798A (en) 1997-06-18 1998-06-17 Application of 13c-13c,13c-15n, and 13c-13c-15n isotopically enriched proteins as tissue-directed image-enhancement reagents for magnetic resonance imaging

Country Status (2)

Country Link
AU (1) AU7972798A (en)
WO (1) WO1998057578A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020102211A1 (en) * 2000-12-07 2002-08-01 Renshaw Perry F. Use of magnetic resonance imaging in diagnosis of membrane fluidity-related disorders
US6521210B2 (en) * 2000-12-13 2003-02-18 Archimedes Technology Group, Inc. Method for imaging malignant tumors using carbon 13 with MRI
US7803352B2 (en) 2003-03-07 2010-09-28 John Steele Fisher Method for continuous visualization of a blood clot or plaque in body lumen
JP5435940B2 (en) 2006-05-17 2014-03-05 大塚製薬株式会社 Magnetic resonance contrast agent and magnetic resonance imaging method using polyethylene glycol
JP5448397B2 (en) 2007-09-07 2014-03-19 キヤノン株式会社 Substrate probe, detection method of enzyme activity by multiple nuclear magnetic resonance method, and imaging method of enzyme activity
JP4954165B2 (en) * 2007-09-07 2012-06-13 キヤノン株式会社 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method
JP5328269B2 (en) * 2007-09-07 2013-10-30 キヤノン株式会社 Nuclear magnetic resonance measurement

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308604A (en) * 1989-04-19 1994-05-03 Deutsches Krebsforschungsinstitut Conjugates for tumor localization and/or tumor therapy
US5094848A (en) * 1989-06-30 1992-03-10 Neorx Corporation Cleavable diphosphate and amidated diphosphate linkers
ES2199226T3 (en) * 1992-09-04 2004-02-16 The General Hospital Corporation BIOCOMPATIBLE POLYMERS CONTAINING DIAGNOSTIC OR THERAPEUTIC HALVES.

Also Published As

Publication number Publication date
WO1998057578A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
IL118121A0 (en) Magnetic resonance imaging system and method
AU2157395A (en) Gas filled microspheres as magnetic resonance imaging contrast agents
PL336889A1 (en) Preparations of activated protein c
AU3900799A (en) Device and method for magnetic separation of biological molecules
AU5445296A (en) Methods for preparing dna-binding proteins
AU3390697A (en) Force-detected nuclear magnetic resonance
AU5719600A (en) Method of obtaining protein isolates and concentrates from colostrum
AUPO615297A0 (en) Imaging system and method
AU3007495A (en) Three-dimensional anisotropy contrast magnetic resonance imaging
AU5085800A (en) Method of magnetic resonance imaging
AU4753997A (en) Magnetic resonance imaging of thrombi
AU8918398A (en) System and method for communicating transaction capabilities application part information
AU5551299A (en) Method of identifying proteins
AU7972798A (en) Application of 13c-13c,13c-15n, and 13c-13c-15n isotopically enriched proteins as tissue-directed image-enhancement reagents for magnetic resonance imaging
AU1419395A (en) Process for fractionating whey proteins and the components so obtained
AU2419695A (en) Contrast medium for magnetic resonance imaging
AU2989495A (en) Separation of human serum albumin
AU4230396A (en) Method for in vitro protein synthesis
EP0886649A4 (en) Protein occlusion for delivery of small molecules
PL345208A1 (en) The induction of antiobiotic proteins and peptides by lait/scd14-protein
GB2337125B (en) Magnetic resonance imaging method for noise-free investigations,in particular of brain activation
AU5649299A (en) Protein solution preparation and method for stabilizing the same
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
AU6966298A (en) Data acquisition for magnetic resonance imaging technique
AU2900695A (en) Process for the preparation of peptide trisulfides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase